CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Calidi Biotherapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.78−0.05 (-6.40%)
Close on Oct 19, 2026
- Market cap
- $1.11M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Calidi Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 21, 2026 | Sep 25, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2026 | Sep 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 10, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 18, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | May 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 8, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 29, 2026 | Apr 2, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 11, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2026 | Feb 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2026 | Jan 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2025 | Oct 31, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 24, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Sep 19, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2025 | Aug 22, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2025 | Jul 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2025 | Jul 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2025 | Jul 10, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 23, 2025 | May 23, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2025 | May 2, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 17, 2025 | Apr 23, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 10, 2025 | SEC EDGAR |